NanoReviv was founded in 2023 by Amokrane REGHAL, MD microbiologist cumulating over 20 years experience in antibiotics (Pasteur Institute, Bayer etc.). Our specialty is reformulating existing molecules to give them a second life. We are currently developing Staph-Ex, a product based on the concept that drug-resistant bacterial infections could be effectively treated by targeted administration of a drug formulation in lipid nanocapsules, combining immediate and controlled release.
NanoReviv project is
Supported by:
Lablised by:
Contact us
-
Parc Eurasanté Ouest,
70 Rue du Dr Yersin,
59120 Loos - +33 (0)6 10 34 17 44
- AREGHAL@NANOREVIV.COM